Avantika Pharma (Distributors) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-12-2024
- Paid Up Capital ₹ 5.00 M
as on 07-12-2024
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.82 Cr
as on 07-12-2024
- Revenue 107.29%
(FY 2021)
- Profit 274.49%
(FY 2021)
- Ebitda 10.66%
(FY 2021)
- Net Worth 38.30%
(FY 2021)
- Total Assets 31.63%
(FY 2021)
About Avantika Pharma (Distributors)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.82 Cr.
Neeraj Shukla, Anuj Shukla, and Yashasvi Shukla serve as directors at the Company.
- CIN/LLPIN
U24231UP1981PTC005394
- Company No.
005394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1981
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Avantika Pharma (Distributors)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Shukla  | Whole-Time Director | 12-Aug-1989 | Current |
| Anuj Shukla | Director | 01-Apr-1999 | Current |
| Yashasvi Shukla | Director | 09-Jun-2021 | Current |
Financial Performance of Avantika Pharma (Distributors).
Avantika Pharma (Distributors) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 107.29% increase. The company also saw a substantial improvement in profitability, with a 274.49% increase in profit. The company's net worth Soared by an impressive increase of 38.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avantika Pharma (Distributors)?
In 2021, Avantika Pharma (Distributors) had a promoter holding of 98.06% and a public holding of 1.94%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avantika Motors Private LimitedActive 13 years 10 monthsNeeraj Shukla, Anuj Shukla and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Oct 2023 | ₹4.69 M | Open |
Uco Bank Creation Date: 25 Mar 2021 | ₹1.25 Cr | Open |
Vijaya Bank Creation Date: 07 Aug 2007 | ₹1.00 M | Open |
How Many Employees Work at Avantika Pharma (Distributors)?
Avantika Pharma (Distributors) has a workforce of 22 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avantika Pharma (Distributors), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avantika Pharma (Distributors)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
